Search Results

Your search for Ana I. Tergas, MD, MPH matches 2 pages

Showing 1 - 2

By Ana I. Tergas, MD, MPH / June 25, 2015

Hormonal Therapy and Risk of Ovarian Cancer

Ovarian cancer is the second most common gynecologic malignancy in the United States, with an estimated 21,290 new cases expected this year. Ovarian cancer causes 5% of all cancer deaths in women, making it responsible for the highest number of gynecologic cancer deaths.1 Age, family history, and...

gynecologic cancers

By Matthew Stenger / June 25, 2015

Meta-analysis Shows Increased Risk of Ovarian Cancer With Menopausal Hormone Therapy

In a study reported in The Lancet, the Collaborative Group on Epidemiological Studies of Ovarian Cancer found that use of menopausal hormone therapy was associated with increased risk of ovarian cancer, with risk being highest among current users.1 The study consisted of meta-analyses of...

Apr

Today In Oncology

Search Results

Your search for Ana I. Tergas, MD, MPH matches 2 pages

Hormonal Therapy and Risk of Ovarian Cancer

Meta-analysis Shows Increased Risk of Ovarian Cancer With Menopausal Hormone Therapy

Adjuvant Pembrolizumab in Renal Cell Carcinoma: Overall Survival in KEYNOTE-564

Combined ICI and VEGF Inhibitor Trials in Cancer Cardiovascular Eligibility Criteria and Adverse Event Reporting

Risk of T-Cell and Second Primary Malignant Neoplasms After CAR T-Cell Therapy

Lack of Research Focused on Older Adults With Cancer May Be Contributing to Disparities in Care

Breast Cancer Survivors: Relationship Satisfaction and Emotional and Physical Well-Being